다약제 내성 그리고 Rifampin 내성 결핵 병이 Multidrug-resistant and Rifampin-resistant tuberculosis disease has become a health problem on this planet, and in 1915, the number of tuberculosis patients with multidrug resistance and Rifampin treatment resistance was 558,000, and 230,000 people died as a result.

다약제 내성 그리고 Rifampin 내성 결핵 병이 이 지구상 건강 문제가 되고 1915년 다약제 내성 그리고 Rifampin  치료에 내성이 생긴  결핵  환자수는 지구상  558,000명이 되고  그로 인해 230.000 명이 사망 했다고 한다.

그래서 요지음 고 량 Moxifloxacin 40주간, kanamycin, prothionamide, 고 량 isoniazid 첯 16주 또는18~24 개월 간 2011 년 부터  치료 한다 .  소스: NEJM, 3/28/2019 

Multidrug-resistant and Rifampin-resistant tuberculosis disease has become a health problem on this planet, and in 1915, the number of tuberculosis patients with multidrug resistance and Rifampin treatment resistance was 558,000, and 230,000 people died as a result.

So, in summary, treatment is started in 2011 with high-dose Moxifloxacin for 40 weeks, kanamycin, prothionamide, and high-dose isoniazid for 16 weeks or 18 to 24 months. Source: NEJM, 3/28/2019